Phospholipase C-β3 Regulates Fce{open}RI-Mediated Mast Cell Activation by Recruiting the Protein Phosphatase SHP-1

Immunity

Volumn 34, Issue 6, 2011, Pages 893-904

  Xiao, Wenbin ^a   Kashiwakura, Jun ichi ^a   Hong, Hong ^a   Yasudo, Hiroki ^a   Ando, Tomoaki ^a   Maeda Yamamoto, Mari ^b   Wu, Dianqing ^c   Kawakami, Yuko ^a   Kawakami, Toshiaki ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b NATIONAL INSTITUTE OF VEGETABLE AND TEA SCIENCE   (Japan)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C BETA3; PROTEIN KINASE LYN; PROTEIN KINASE P60; PROTEIN TYROSINE PHOSPHATASE SHP 1; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL MUTANT; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE; INFLAMMATION; MAST CELL; MOUSE; NONHUMAN; PHENOTYPE; PLCB3 GENE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN MOTIF; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CYTOKINES; MAST CELLS; MICE; MICE, KNOCKOUT; MUTATION; PHOSPHOLIPASE C BETA; PHOSPHOTYROSINE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RECEPTORS, IGE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 79959354701     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2011.04.010     Document Type: Article

References (62)

1. Abramson J., Rozenblum G., Pecht I. Dok protein family members are involved in signaling mediated by the type 1 Fcepsilon receptor. Eur. J. Immunol. 2003, 33:85-91.
2. Abu-Dayyeh I., Shio M.T., Sato S., Akira S., Cousineau B., Olivier M. Leishmania-induced IRAK-1 inactivation is mediated by SHP-1 interacting with an evolutionarily conserved KTIM motif. PLoS Negl. Trop. Dis. 2008, 2:e305.
3. Abu-Dayyeh I., Ralph B., Grayfer L., Belosevic M., Cousineau B., Olivier M. Identification of key cytosolic kinases containing evolutionarily conserved kinase tyrosine-based inhibitory motifs (KTIMs). Dev. Comp. Immunol. 2010, 34:481-484.
4. Edmunds C., Parry R.V., Burgess S.J., Reaves B., Ward S.G. CD28 stimulates tyrosine phosphorylation, cellular redistribution and catalytic activity of the inositol lipid 5-phosphatase SHIP. Eur. J. Immunol. 1999, 29:3507-3515.
5. Eiseman E., Bolen J.B. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature 1992, 355:78-80.
6. Field K.A., Holowka D., Baird B. Fc epsilon RI-mediated recruitment of p53/56lyn to detergent-resistant membrane domains accompanies cellular signaling. Proc. Natl. Acad. Sci. USA 1995, 92:9201-9205.
7. Fluckiger A.C., Li Z., Kato R.M., Wahl M.I., Ochs H.D., Longnecker R., Kinet J.P., Witte O.N., Scharenberg A.M., Rawlings D.J. Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J. 1998, 17:1973-1985.
8. Freeburn R.W., Wright K.L., Burgess S.J., Astoul E., Cantrell D.A., Ward S.G. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors. J. Immunol. 2002, 169:5441-5450.
9. Furumoto Y., Nunomura S., Terada T., Rivera J., Ra C. The FcepsilonRIbeta immunoreceptor tyrosine-based activation motif exerts inhibitory control on MAPK and IkappaB kinase phosphorylation and mast cell cytokine production. J. Biol. Chem. 2004, 279:49177-49187.
10. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., Tsai M. Mast cells as " tunable" effector and immunoregulatory cells: Recent advances. Annu. Rev. Immunol. 2005, 23:749-786.
11. Gilfillan A.M., Rivera J. The tyrosine kinase network regulating mast cell activation. Immunol. Rev. 2009, 228:149-169.
12. Gilfillan A.M., Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 2006, 6:218-230.
13. Gimborn K., Lessmann E., Kuppig S., Krystal G., Huber M. SHIP down-regulates FcepsilonR1-induced degranulation at supraoptimal IgE or antigen levels. J. Immunol. 2005, 174:507-516.
14. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004, 18:2195-2224.
15. Hernandez-Hansen V., Smith A.J., Surviladze Z., Chigaev A., Mazel T., Kalesnikoff J., Lowell C.A., Krystal G., Sklar L.A., Wilson B.S., Oliver J.M. Dysregulated FcepsilonRI signaling and altered Fyn and SHIP activities in Lyn-deficient mast cells. J. Immunol. 2004, 173:100-112.
16. Hibbs M.L., Harder K.W., Armes J., Kountouri N., Quilici C., Casagranda F., Dunn A.R., Tarlinton D.M. Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. J. Exp. Med. 2002, 196:1593-1604.
17. Huber M., Helgason C.D., Damen J.E., Liu L., Humphries R.K., Krystal G. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc. Natl. Acad. Sci. USA 1998, 95:11330-11335.
18. Hunter T. Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling. Cell 1995, 80:225-236.
19. Inagaki N., Goto S., Yamasaki M., Nagai H., Koda A. Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear. Int. Arch. Allergy Appl. Immunol. 1986, 80:285-290.
20. Jouvin M.H., Adamczewski M., Numerof R., Letourneur O., Vallé A., Kinet J.P. Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high affinity immunoglobulin E receptor. J. Biol. Chem. 1994, 269:5918-5925.
21. Kalesnikoff J., Galli S.J. New developments in mast cell biology. Nat. Immunol. 2008, 9:1215-1223.
22. Kalesnikoff J., Baur N., Leitges M., Hughes M.R., Damen J.E., Huber M., Krystal G. SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-kappa B activity. J. Immunol. 2002, 168:4737-4746.
23. Kawakami Y., Kitaura J., Satterthwaite A.B., Kato R.M., Asai K., Hartman S.E., Maeda-Yamamoto M., Lowell C.A., Rawlings D.J., Witte O.N., Kawakami T. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation. J. Immunol. 2000, 165:1210-1219.
24. Kimura T., Sakamoto H., Appella E., Siraganian R.P. The negative signaling molecule SH2 domain-containing inositol-polyphosphate 5-phosphatase (SHIP) binds to the tyrosine-phosphorylated beta subunit of the high affinity IgE receptor. J. Biol. Chem. 1997, 272:13991-13996.
25. Kimura T., Zhang J., Sagawa K., Sakaguchi K., Appella E., Siraganian R.P. Syk-independent tyrosine phosphorylation and association of the protein tyrosine phosphatases SHP-1 and SHP-2 with the high affinity IgE receptor. J. Immunol. 1997, 159:4426-4434.
26. Kinet J.P. The high-affinity IgE receptor (Fc epsilon RI): From physiology to pathology. Annu. Rev. Immunol. 1999, 17:931-972.
27. Kitaura J., Asai K., Maeda-Yamamoto M., Kawakami Y., Kikkawa U., Kawakami T. Akt-dependent cytokine production in mast cells. J. Exp. Med. 2000, 192:729-740.
28. Kitaura J., Song J., Tsai M., Asai K., Maeda-Yamamoto M., Mocsai A., Kawakami Y., Liu F.T., Lowell C.A., Barisas B.G., et al. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc. Natl. Acad. Sci. USA 2003, 100:12911-12916.
29. Klemm S., Gutermuth J., Hültner L., Sparwasser T., Behrendt H., Peschel C., Mak T.W., Jakob T., Ruland J. The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation. J. Exp. Med. 2006, 203:337-347.
30. Kozlowski M., Mlinaric-Rascan I., Feng G.S., Shen R., Pawson T., Siminovitch K.A. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J. Exp. Med. 1993, 178:2157-2163.
31. Leung W.H., Bolland S. The inositol 5'-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production. J. Immunol. 2007, 179:95-102.
32. Liang X., Wisniewski D., Strife A., Shivakrupa, Clarkson B., Resh M.D. Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling. J. Biol. Chem. 2002, 277:13732-13738.
33. Mashima R., Hishida Y., Tezuka T., Yamanashi Y. The roles of Dok family adapters in immunoreceptor signaling. Immunol. Rev. 2009, 232:273-285.
34. Nakata K., Yoshimaru T., Suzuki Y., Inoue T., Ra C., Yakura H., Mizuno K. Positive and negative regulation of high affinity IgE receptor signaling by Src homology region 2 domain-containing phosphatase 1. J. Immunol. 2008, 181:5414-5424.
35. Nishida K., Yamasaki S., Ito Y., Kabu K., Hattori K., Tezuka T., Nishizumi H., Kitamura D., Goitsuka R., Geha R.S., et al. FcepsilonRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane. J. Cell Biol. 2005, 170:115-126.
36. Nishida K., Hasegawa A., Nakae S., Oboki K., Saito H., Yamasaki S., Hirano T. Zinc transporter Znt5/Slc30a5 is required for the mast cell-mediated delayed-type allergic reaction but not the immediate-type reaction. J. Exp. Med. 2009, 206:1351-1364.
37. Odom S., Gomez G., Kovarova M., Furumoto Y., Ryan J.J., Wright H.V., Gonzalez-Espinosa C., Hibbs M.L., Harder K.W., Rivera J. Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J. Exp. Med. 2004, 199:1491-1502.
38. Ott V.L., Cambier J.C. Activating and inhibitory signaling in mast cells: New opportunities for therapeutic intervention?. J. Allergy Clin. Immunol. 2000, 106:429-440.
39. Ozawa K., Szallasi Z., Kazanietz M.G., Blumberg P.M., Mischak H., Mushinski J.F., Beaven M.A. Ca(2+)-dependent and Ca(2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory responses with Ca2+ and purified isozymes in washed permeabilized cells. J. Biol. Chem. 1993, 268:1749-1756.
40. Parravicini V., Gadina M., Kovarova M., Odom S., Gonzalez-Espinosa C., Furumoto Y., Saitoh S., Samelson L.E., O'Shea J.J., Rivera J. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunol. 2002, 3:741-748.
41. Phee H., Jacob A., Coggeshall K.M. Enzymatic activity of the Src homology 2 domain-containing inositol phosphatase is regulated by a plasma membrane location. J. Biol. Chem. 2000, 275:19090-19097.
42. Poderycki M., Tomimori Y., Ando T., Xiao W., Maeda-Yamamoto M., Sauer K., Kawakami Y., Kawakami T. A minor catalytic activity of Src family kinases is sufficient for maximal activation of mast cells via the high-affinity IgE receptor. J. Immunol. 2010, 184:84-93.
43. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 2001, 70:281-312.
44. Rivera J., Gilfillan A.M. Molecular regulation of mast cell activation. J. Allergy Clin. Immunol. 2006, 117:1214-1225. quiz 1226.
45. Saitoh S., Arudchandran R., Manetz T.S., Zhang W., Sommers C.L., Love P.E., Rivera J., Samelson L.E. LAT is essential for Fc(epsilon)RI-mediated mast cell activation. Immunity 2000, 12:525-535.
46. Somani A.K., Yuen K., Xu F., Zhang J., Branch D.R., Siminovitch K.A. The SH2 domain containing tyrosine phosphatase-1 down-regulates activation of Lyn and Lyn-induced tyrosine phosphorylation of the CD19 receptor in B cells. J. Biol. Chem. 2001, 276:1938-1944.
47. Suh P.G., Park J.I., Manzoli L., Cocco L., Peak J.C., Katan M., Fukami K., Kataoka T., Yun S., Ryu S.H. Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep 2008, 41:415-434.
48. Taube C., Wei X., Swasey C.H., Joetham A., Zarini S., Lively T., Takeda K., Loader J., Miyahara N., Kodama T., et al. Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. J. Immunol. 2004, 172:6398-6406.
49. Tolar P., Dráberová L., Tolarová H., Dráber P. Positive and negative regulation of Fc epsilon receptor I-mediated signaling events by Lyn kinase C-terminal tyrosine phosphorylation. Eur. J. Immunol. 2004, 34:1136-1145.
50. Turner H., Kinet J.P. Signalling through the high-affinity IgE receptor Fc epsilonRI. Nature 1999, 402(6760, Suppl):B24-B30.
51. Wang D., Feng J., Wen R., Marine J.C., Sangster M.Y., Parganas E., Hoffmeyer A., Jackson C.W., Cleveland J.L., Murray P.J., Ihle J.N. Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity 2000, 13:25-35.
52. Wershil B.K., Wang Z.S., Gordon J.R., Galli S.J. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J. Clin. Invest. 1991, 87:446-453.
53. Williams C.M., Galli S.J. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J. Exp. Med. 2000, 192:455-462.
54. Wilson B.S., Pfeiffer J.R., Oliver J.M. Observing FcepsilonRI signaling from the inside of the mast cell membrane. J. Cell Biol. 2000, 149:1131-1142.
55. Wilson B.S., Steinberg S.L., Liederman K., Pfeiffer J.R., Surviladze Z., Zhang J., Samelson L.E., Yang L.H., Kotula P.G., Oliver J.M. Markers for detergent-resistant lipid rafts occupy distinct and dynamic domains in native membranes. Mol. Biol. Cell 2004, 15:2580-2592.
56. Xiao W., Nishimoto H., Hong H., Kitaura J., Nunomura S., Maeda-Yamamoto M., Kawakami Y., Lowell C.A., Ra C., Kawakami T. Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI. J. Immunol. 2005, 175:6885-6892.
57. Xiao W., Hong H., Kawakami Y., Kato Y., Wu D., Yasudo H., Kimura A., Kubagawa H., Bertoli L.F., Davis R.S., et al. Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5. Cancer Cell 2009, 16:161-171.
58. Xiao W., Ando T., Wang H.Y., Kawakami Y., Kawakami T. Lyn- and PLC-beta3-dependent regulation of SHP-1 phosphorylation controls Stat5 activity and myelomonocytic leukemia-like disease. Blood 2010, 116:6003-6013.
59. Xie Z.H., Zhang J., Siraganian R.P. Positive regulation of c-Jun N-terminal kinase and TNF-alpha production but not histamine release by SHP-1 in RBL-2H3 mast cells. J. Immunol. 2000, 164:1521-1528.
60. Yamashita Y., Charles N., Furumoto Y., Odom S., Yamashita T., Gilfillan A.M., Constant S., Bower M.A., Ryan J.J., Rivera J. Cutting edge: Genetic variation influences Fc epsilonRI-induced mast cell activation and allergic responses. J. Immunol. 2007, 179:740-743.
61. Yang W., Mckenna S.D., Jiao H., Tabrizi M., Lynes M.A., Shultz L.D., Yi T. SHP-1 deficiency in B-lineage cells is associated with heightened lyn protein expression and increased lyn kinase activity. Exp. Hematol. 1998, 26:1126-1132.
62. Yoshida K., Kharbanda S., Kufe D. Functional interaction between SHPTP1 and the Lyn tyrosine kinase in the apoptotic response to DNA damage. J. Biol. Chem. 1999, 274:34663-34668.